Highest-materiality recent filing
Cardiff Lexington enters up to $75M equity purchase agreement with Leonite Fund I
Commits to sell up to $25M in common stock; Company may increase to $75M at its sole discretion.
Cardiff Lexington amends Series N preferred stock to remove redemption provisions
Filed Certificate of Amendment on Jan 29, 2026.
Board Chairman Daniel Thompson resigns; CEO Alex Cunningham appointed Chairman
Daniel Thompson resigned from Board of Directors and as Chairman on December 31, 2025.
Audit Committee concluded that financials from Q1 2024 to Q1 2025 should no longer be relied upon.
Cardiff Lexington amends preferred stock terms; Series Y authorized to 1.25M
Filed Certificates of Amendment for Series B, C, E, I, and Y preferred stock on Nov 27, 2024.
Cardiff Lexington restates Q1 and Q2 2024 financials due to credit loss classification errors
Board determined Q1 & Q2 2024 financial statements and prior-year comparatives should no longer be relied upon.
Grassi & Co. resigned as independent auditor effective Sept 13, 2024; no disagreements or reportable events.
Cardiff Lexington settles prior convertible notes; issues $535K settlement note tied to offering
Settlement with GHS Investments terminates 2019-2020 Transaction Agreements including convertible preferred stock and notes.
Cardiff Lexington terminates CAO Zia Choe in accounting restructuring
Zia Choe terminated as Chief Accounting Officer effective June 5, 2024.
Cardiff Lexington exchanges $3.76M note for 938,908 Series Y preferred shares; grants asset security
Exchanged $3,755,632 consolidated convertible note with Leonite Capital for 938,908 shares of newly designated Series Y senior convertible preferred stock.
Stockholders approve Cardiff Lexington's 2024 Equity Incentive Plan via written consent
Stockholders holding ~82% of voting power consented to adopt the 2024 Equity Incentive Plan.
Cardiff Lexington appoints Matthew Shafer CFO, Zia Choe CAO
Steven Healy resigned as CFO on March 1, 2023; not due to any disagreement.
Cardiff Lexington settles two convertible notes for $175,000, extinguishing $187k debt
Settled convertible promissory notes dated Feb 9, 2021 and Apr 26, 2021 from PowerUp Lending Group.
Cardiff Lexington enters $4.5M accounts receivable purchase agreement with DML HC Series
Initial advance of $500K, max $4.5M, to purchase pools of accounts receivable from subsidiary Nova Ortho and Spine.
Cardiff Lexington stockholders approve charter amendment to restructure preferred stock terms
Holders representing approx. 80% of voting power consented in writing to approve the Charter Amendment.
Stockholders approve 1-for-75,000 reverse stock split for Cardiff Lexington
Stockholders holding ~81% of voting power consented in writing to approve the reverse split.
Cardiff Lexington amends bylaws to remove 12 classes of preferred stock
Board voted on Nov 23, 2022 to amend and restate Bylaws effective immediately.
Cardiff Lexington dismisses auditor RRBB over prior restatement delays; appoints Grassi & Co.
Dismissed Rosenberg Rich Baker Berman PA, effective March 16, 2022, after RRBB cited capacity issues completing reviews.
Cardiff Lexington non-reliance on 2020 annual and Q1 2021 financials; will restate
Restated periods: year ended Dec 31, 2020, and quarter ended March 31, 2021.
Cardiff Lexington sells Key Tax subsidiary to management for $2.6M via stock swap
Sale of JM Enterprises1 (dba Key Tax) to managers Kelly Gibson and Ron Clere via exchange of Preferred "G" shares valued at $2,601,952.
Cardiff Lexington issues pro forma financials showing 2020 revenue up 43%, EBITDA loss narrowed 69%
Combined 2020 revenue $7,597,814 (+43% vs 2019); EBITDA loss -$1,684,212 (improved 69% from -$5,438,867).
On June 5, 2024, Cardiff Lexington Corporation (the “Company”) terminated Zia Choe from her position as Chief Accounting Officer of the Company in connection with a restructuring of the Company’s accounting department.
On March 1, 2023, Steven Healy resigned from his position as Chief Financial Officer of Cardiff Lexington Corporation (the “Company”). Mr. Healy’s resignation was not due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
On the same date, the Board of Directors appointed Matthew T. Shafer as Chief Financial Officer.
On March 1, 2023, the Board of Directors of the Company appointed Zia Choe to serve as Interim Chief Financial Officer of the Company.
On January 2, 2024, Ms. Choe resigned as Interim Chief Financial Officer and the Board of Directors of the Company appointed Ms. Choe as Chief Accounting Officer of the Company.
Max materiality 0.90 · Median 0.60 · Most common event other_material